secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001628280-24-024936
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corcept Therapeutics shareholders approve 2024 Incentive Award Plan adding 8M new shares
--------------------------------------------------------------------------------

- 2024 Plan replaces 2012 plan; total shares authorized = 8M new + 4,073,955 carryover + lapsed awards.
- All 9 director nominees elected; vote range 56.9M to 65.6M for (excluding broker non-votes).
- Ernst & Young ratified as auditor for FY2024: 86.6M for, 1.7M against.
- Advisory say-on-pay approved: 64.5M for, 1.0M against; 22.5M broker non-votes.
- 2024 Plan passed with 47.0M for, 18.7M against; 22.5M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000162828024024936/0001628280-24-024936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000162828024024936/cort-20240517.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-024936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer